Humanin: A novel central regulator of peripheral insulin action

PLoS ONE

Volumn 4, Issue 7, 2009, Pages

  Muzumdar, Radhika H ^a,b   Huffman, Derek M ^b   Atzmon, Gil ^b   Buettner, Cristoph ^c   Cobb, Laura J ^d   Fishman, Sigal ^b   Budagov, Temuri ^b   Cui, Lingguang ^b   Einstein, Francine H ^b   Poduval, Aruna ^a   Hwang, David ^d   Barzilai, Nir ^b   Cohen, Pinchas ^d  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; F6AHN; HNGF6A; HUMANIN; INSULIN; SOMATOMEDIN BINDING PROTEIN 3; STAT3 PROTEIN; UNCLASSIFIED DRUG; SIGNAL PEPTIDE;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG BRAIN LEVEL; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG MUSCLE LEVEL; DRUG POTENCY; DRUG POTENTIATION; EMBRYO; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HYPOTHALAMUS; INSULIN SENSITIVITY; LIVER CELL; MALE; MOUSE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ALZHEIMER DISEASE; ANIMAL; INSULIN RESISTANCE; LIVER; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ZUCKER RAT;

MUS; RATTUS; RODENTIA;

ALZHEIMER DISEASE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER;

EID: 67749140106     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006334     Document Type: Article

References (42)

1. Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, et al. (2001) A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci U S A 98: 6336-6341.
2. Guo B, Zhai D, Cabezas E, Welsh K, Nouraini S, et al. (2003) Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423: 456-461.
3. Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, et al. (2002) Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett 324: 227-231.
4. Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, et al. (2001) Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci 21: 9235-9245.
5. Sponne I, Fifre A, Koziel V, Kriem B, Oster T, et al. (2004) Humanin rescues cortical neurons from prion-peptide-induced apoptosis. Mol Cell Neurosci 25: 95-102.
6. Mamiya T, Ukai M (2001) [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo. Br J Pharmacol 134: 1597-1599.
7. Tajima H, Kawasumi M, Chiba T, Yamada M, Yamashita K, et al. (2005) A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res 79: 714-723.
8. Jung SS, Van Nostrand WE (2003) Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity. J Neurochem 84: 266-272.
9. Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, et al. (2002) Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 13: 903-907.
10. Hashimoto Y, Terashita K, Niikura T, Yamagishi Y, Ishizaka M, et al. (2004) Humanin antagonists: mutants that interfere with dimerization inhibit neuroprotection by Humanin. Eur J Neurosci 19: 2356-2364.
11. Ikonen M, Liu B, Hashimoto Y, Ma L, Lee KW, et al. (2003) Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A 100: 13042-13047.
12. Harada M, Habata Y, Hosoya M, Nishi K, Fujii R, et al. (2004) N-Formylated humanin activates both formyl peptide receptor-like 1 and 2. Biochem Biophys Res Commun 324: 255-261.
13. Hashimoto Y, Kurita M, Aiso S, Nishimoto I, Matsuoka M (2009) Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor {alpha}/WSX-1/gp130. Mol Biol Cell.
14. Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, et al. (2005) Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci 77: 3092-3104.
15. Wang D, Li H, Yuan H, Zheng M, Bai C, et al. (2005) Humanin delays apoptosis in K562 cells by downregulation of P38 MAP kinase. Apoptosis 10: 963-971.
16. Hashimoto Y, Tsuji O, Niikura T, Yamagishi Y, Ishizaka M, et al. (2003) Involvement of c-Jun N-terminal kinase in amyloid precursor protein-mediated neuronal cell death. J Neurochem 84: 864-877.
17. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, et al. (2000) Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 275: 33607-33613.
18. Kim HS, Ali O, Shim M, Lee KW, Vuguin P, et al. (2007) Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo. Pediatr Res 61: 159-164.
19. Muzumdar RH, Ma X, Fishman S, Yang X, Atzmon G, et al. (2006) Central and opposing effects of IGF-I and IGF-binding protein-3 on systemic insulin action. Diabetes 55: 2788-2796.
20. Craft S (2005) Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol Aging 26 Suppl 1: 65-69.
21. Muzumdar R, Ma X, Yang X, Atzmon G, Bernstein J, et al. (2003) Physiologic effect of leptin on insulin secretion is mediated mainly through central mechanisms. Faseb J 17: 1130-1132.
22. Liu L, Karkanias GB, Morales JC, Hawkins M, Barzilai N, et al. (1998) Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem 273: 31160-31167.
23. Buettner C, Pocai A, Muse ED, Etgen AM, Myers MG Jr, et al. (2006) Critical role of STAT3 in leptin's metabolic actions. Cell Metab. pp 49-60.
24. Berry MN, Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 43: 506-520.
25. Leffert HL, Koch KS, Moran T, Williams M (1979) Liver cells. Methods Enzymol 58: 536-544.
26. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953.
27. Terashita K, Hashimoto Y, Niikura T, Tajima H, Yamagishi Y, et al. (2003) Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: functional potentiation by isomerization and dimerization. J Neurochem 85: 1521-1538.
28. Turkson J, Ryan D, Kim JS, Zhang Y, Chen Z, et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 276: 45443-45455.
29. Inoue H, Ogawa W, Asakawa A, Okamoto Y, Nishizawa A, et al. (2006) Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 3: 267-275.
30. Pocai A, Lam TK, Gutierrez-Juarez R, Obici S, Schwartz GJ, et al. (2005) Hypothalamic K(ATP) channels control hepatic glucose production. Nature 434: 1026-1031.
31. Duanmu Z, Scislo T, Dunbar JC (1999) Glycemic modulation of insulin/ IGF-1 mediated skeletal muscle blood following sympathetic denervation in normal rats. Clin Exp Hypertens 21: 1239-1255.
32. Richards RJ, Blalock A, Liao J, Reisin E (2003) Leptin: sympathetic and cardiovascular effects. Curr Cardiol Rep 5: 453-458.
33. Li ZG, Zhang W, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56: 1817-1824.
34. Pedersen WA, McMillan PJ, Kulstad JJ, Leverenz JB, Craft S, et al. (2006) Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp Neurol 199: 265-273.
35. Rensink AA, Gellekink H, Otte-Holler I, ten Donkelaar HJ, de Waal RM, et al. (2002) Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease. Acta Neuropathol (Berl) 104: 525-533.
36. Miao J, Zhang W, Yin R, Liu R, Su C, et al. (2008) S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice. Neuropeptides 42: 557-567.
37. Xu X, Chua CC, Gao J, Hamdy RC, Chua BH (2006) Humanin is a novel neuroprotective agent against stroke. Stroke 37: 2613-2619.
38. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, et al. (2004) Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci U S A 101: 4661-4666.
39. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443: 796-802.
40. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I (2002) Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 8: 1390-1397.
41. Frederiksen AL, Jeppesen TD, Vissing J, Schwartz M, Kyvik KO, et al. (2009) High prevalence of impaired glucose homeostasis and myopathy in a- and oligosymptomatic 3243A>G mtDNA mutation-positive subjects. J Clin Endocrinol Metab.
42. Loeb LA, Wallace DC, Martin GM (2005) The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations. Proc Natl Acad Sci U S A 102: 18769-18770.